The U.S. tracheal tube introducers market is anticipated to reach USD 97.21 million by 2030, growing at a CAGR of 4.82% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by numerous factors such as surgical procedures and strategic activities by the players in the country. The increasing hospital admissions for surgeries and emergency conditions emerges as a significant opportunity in the U.S. tracheal tube introducers market. For instance, as per the article published in the journal “Critical Care Medicine” in September 2024, there were 18,313,637 ICU hospitalizations in Medicare in the U.S. This high number of hospitalizations increases the need for efficient airway management in hospitals and clinics.
Furthermore, a significant number of the young population is attracted to smoking and tobacco habits, which correspondingly impacts the number of respiratory diseases. According to the data published by the CDC in September 2024, around 49.2 million adults living in the U.S. reported tobacco use. Moreover, according to the data published by the American Lung Association in January 2024, around 11.6% of U.S. adults smoked cigarettes in 2022. Thus, an increasing number of individuals are anticipated to suffer from respiratory and chronic illnesses due to the presence of a large population having smoking habits. This increasing prevalence of respiratory illnesses is anticipated to boost the demand for early airway interventions in case of emergencies and thus propel the market growth.
Moreover, studies ongoing in the industry provide reliable information and are anticipated to increase the adoption of tracheal tube introducers. For instance, according to an article published by the Association of Anesthetics in July 2024, a study was performed to understand tracheal tube introducer-associated airway trauma. The study concluded that the tracheal tube introducers are safe and reduce the risk of airway trauma. Furthermore, the study published by the Annals of Emergency Medicine in February 2024 found that the bougie (an endotracheal tube introducer), as an asset in the first intubation attempt, was associated with improved success in emergency department intubations. This study suggests that bougie should probably be used first and not as a rescue device. Thus, such studies are anticipated to support U.S. tracheal tube introducers market growth in the coming years.
Request a free sample copy or view report summary: U.S. Tracheal Tube Introducers Market Report
Based on end use, the EMS (Fire/Rescue/Ambulance/Hospital Based EMS) segment dominated the market and accounted for a revenue share of 39.21% in 2024. On the other hand, the hospitals and clinics segment is expected to register the fastest CAGR during the forecast period owing to the increasing demand and advanced healthcare infrastructure
Intersurgical, Flexicare (Group) Limited, MEDLINE, Vygon SAS, and Dynarex Corporation are the key players in the U.S. tracheal tube introducers market.
Grand View Research has segmented the U.S. tracheal tube introducers market on the basis of end use:
U.S. Tracheal Tube Introducers End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals and Clinics
Ambulatory Surgical Centers
Emergency Care Facilities/Urgent Care
Others (Long-Term Facilities, Physician Offices, Nursing Homes)
EMS (Fire/Rescue/Ambulance/Hospital Based EMS)
List of key players in the U.S. Tracheal Tube Introducers Market
Intersurgical
Flexicare (Group) Limited
MEDLINE
Dynarex Corporation
Vygon SAS
"The quality of research they have done for us has been excellent..."